French drugmaker Sanofi has just invested $59 million in biotech investor Jeito Capital to fund innovation in the biopharma pipeline



logo: FILE PHOTO: Sanofi logo is seen in Paris Reuters


© Reuters
FILE PHOTO: Sanofi logo is seen in Paris Reuters

  • Sanofi, one of the world’s biggest pharmaceutical companies, has invested €50 million in new French-based VC Jeito Capital.
  • Jeito CEO Rafaèle Tordjman, managing director of innovation at Jeito Capital, spoke with Business Insider about how the fund plans to invest the money.
  • Jeito’s first fund has already invested in two companies, with plans to invest in a further 4-5 in the next year.
  • Visit Business Insider’s homepage for more stories.

France’s Sanofi, one of the world’s biggest pharmaceutical companies, has invested €50 million ($59 million) in venture capital firm Jeito Capital, Jeito CEO Rafaèle Tordjman said on Friday.

Loading...

Load Error

Jeito Capital, a Paris-based venture capital firm, plans to invest in biopharma and biotech companies across all different funding stages. Sanofi is the world’s fifth-largest drugmaker by prescription sales. Its better known over-the-counter brands include anti-acid products such as

Read More